Published in Br J Pharmacol on April 01, 1998
Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice. Infect Immun (2006) 1.19
Free radical production requires both inducible nitric oxide synthase and xanthine oxidase in LPS-treated skin. Proc Natl Acad Sci U S A (2006) 1.08
Evidence that mast cell degranulation, histamine and tumour necrosis factor alpha release occur in LPS-induced plasma leakage in rat skin. Br J Pharmacol (1999) 0.99
Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1. PLoS Pathog (2010) 0.90
Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide. Br J Pharmacol (2000) 0.84
Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. Clin Dev Immunol (2013) 0.81
Beneficial effects of caffeic acid phenethyl ester in a rat model of vascular injury. Br J Pharmacol (2002) 0.79
Airway hyperresponsiveness to adenosine induced by lipopolysaccharide in Brown Norway rats. Br J Pharmacol (2002) 0.78
Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol (1971) 6.97
Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature (1990) 5.57
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature (1980) 4.29
Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science (2000) 4.04
Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb Res (1977) 3.28
Screens for anti-inflammatory drugs. J Pharm Pharmacol (1971) 3.24
Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ (2008) 2.84
Biological properties of carrageenan. J Pharm Pharmacol (1972) 2.58
Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol (1992) 2.32
Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun (1990) 2.31
A histopathological and pharmacological analysis of the mode of action of nonsteroidal anti-inflammatory drugs. J Pathol (1971) 2.15
Non-adrenergic non-cholinergic relaxation mediated by nitric oxide in the canine ileocolonic junction. Eur J Pharmacol (1990) 2.04
Release of nitric oxide upon stimulation of nonadrenergic noncholinergic nerves in the rat gastric fundus. J Pharmacol Exp Ther (1991) 2.02
Anti-phospholipase proteins. Prostaglandins (1984) 1.93
Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res (2001) 1.92
Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem (2000) 1.86
Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther (2000) 1.81
Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation (1998) 1.77
Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br J Pharmacol (1982) 1.74
Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol (1993) 1.72
Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine (1992) 1.58
Apoptosis in atherosclerosis: beneficial or detrimental? Cardiovasc Res (2000) 1.58
A nitric oxide synthase inhibitor reduces inflammation, down-regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology (1994) 1.54
Impaired endothelium-dependent cholinergic coronary vasodilation in patients with angina and normal coronary arteriograms. J Am Coll Cardiol (1992) 1.50
Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol (1992) 1.45
Evidence for a differential release of nitric oxide and vasoactive intestinal polypeptide by nonadrenergic noncholinergic nerves in the rat gastric fundus. Arch Int Pharmacodyn Ther (1993) 1.42
Mesotheliomas following exposure to asbestos used in railroads: 130 Italian cases. Med Lav (1996) 1.38
Hydrocortisone-induced inhibitor of prostaglandin biosynthesis in rat leucocytes. Br J Pharmacol (1980) 1.36
Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol (1989) 1.36
The inhibition by hydrocortisone of prostaglandin biosynthesis in rat peritoneal leucocytes is correlated with intracellular macrocortin levels. Br J Pharmacol (1981) 1.34
Mechanism of inhibition of prostaglandin biosynthesis by hydrocortisone in rat leucocytes. Br J Pharmacol (1979) 1.34
Structural elucidation of a new cytotoxin isolated from mussels of the Adriatic sea. J Org Chem (2001) 1.30
Prostaglandin production by rabbit isolated jejunum and its relationship to the inherent tone of the preparation. Br J Pharmacol (1976) 1.29
Reactive oxygen species induce RNA damage in human atherosclerosis. Eur J Clin Invest (2004) 1.22
Evidence for nitric oxide as mediator of non-adrenergic non-cholinergic relaxations induced by ATP and GABA in the canine gut. Br J Pharmacol (1991) 1.20
Bioassay of nitric oxide released upon stimulation of non-adrenergic non-cholinergic nerves in the canine ileocolonic junction. Br J Pharmacol (1991) 1.17
Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc Res (1999) 1.17
Inflammatory properties of recombinant tumor necrosis factor in rabbit skin in vivo. J Exp Med (1989) 1.17
Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br J Pharmacol (1995) 1.16
Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett (1997) 1.15
Inflammatory effects of Salmonella typhimurium porins. Infect Immun (1990) 1.14
L-arginine-dependent production of nitrogen oxides by rat pulmonary macrophages. Eur J Pharmacol (1991) 1.14
Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry (1997) 1.13
Sequential induction of nitric oxide synthase by Corynebacterium parvum in different organs of the mouse. Br J Pharmacol (1995) 1.12
Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in vivo. Eur J Pharmacol (1992) 1.11
Acetylcholine is an indirect inhibitory transmitter in the canine ileocolonic junction. Eur J Pharmacol (1989) 1.11
Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages. J Clin Lab Anal (2005) 1.09
Biosynthesis of prostaglandin (PGI2) and 12L-hydroxy-5,8,10,14-eicosatetraenoic acid (HETE) by pericardium, pleura, peritoneum and aorta of the rabbit. Prostaglandins (1979) 1.09
The mechanism of the inflammatory effect of carrageenin. Eur J Pharmacol (1968) 1.07
Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res (1998) 1.07
Triphasic sequence of neointimal formation in the cuffed carotid artery of the rabbit. Arterioscler Thromb (1992) 1.07
Effect of adrenergic and nitrergic blockade on experimental ileus in rats. Br J Pharmacol (1997) 1.05
TRPV1 receptors on unmyelinated C-fibres mediate colitis-induced sensitization of pelvic afferent nerve fibres in rats. J Physiol (2008) 1.05
Blood levels of 6-oxo-prostaglandin F 1 alpha during endotoxin-induced hypotension in rabbits. Eur J Pharmacol (1980) 1.05
Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. Atherosclerosis (1996) 1.05
Acetylcholine stimulates the release of prostacyclin by rabbit aorta endothelium. J Pharm Pharmacol (1983) 1.04
Vascular endothelial dysfunction. Prog Cardiovasc Dis (1997) 1.04
Some pharmacodynamic properties of carrageenin in the rat. Br J Pharmacol (1970) 1.03
Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice. Neurogastroenterol Motil (2004) 1.02
Indomethacin and prostaglandins. Eur J Pharmacol (1972) 1.01
Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. Br J Pharmacol (1987) 1.01
Quantitative determination of 6-Oxo-PGF1 alpha in biological fluids by gas chromatography mass spectrometry. Biomed Mass Spectrom (1980) 1.01
Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J Clin Invest (1999) 1.01
Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol Lett (2007) 1.00
Role of tumor necrosis factor-alpha in acute hypovolemic hemorrhagic shock in rats. Am J Physiol (1994) 1.00
Involvement of nitric oxide in the inhibitory innervation of the human isolated colon. Gastroenterology (1993) 1.00
Evidence that mast cell degranulation, histamine and tumour necrosis factor alpha release occur in LPS-induced plasma leakage in rat skin. Br J Pharmacol (1999) 0.99
Multiple control of inflammation by glucocorticoids. Agents Actions (1986) 0.99
New insight in LPS antagonist. Mini Rev Med Chem (2009) 0.98
Selective M3 muscarinic receptor antagonists inhibit smooth muscle contraction in rabbit trachea without increasing the release of acetylcholine. J Pharmacol Exp Ther (1992) 0.98
The role of nitric oxide in inhibitory non-adrenergic non-cholinergic neurotransmission in the canine lower oesophageal sphincter. Br J Pharmacol (1991) 0.98
Leucocyte migration and lysosomal enzymes release in rat carrageenin pleurisy. Agents Actions (1975) 0.98
Lung serotonin uptake kinetics from indicator-dilution and constant-infusion methods. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.98
Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut (2006) 0.97
CD4⁺ but not CD8⁺ T cells revert the impaired emotional behavior of immunocompromised RAG-1-deficient mice. Transl Psychiatry (2013) 0.97
Formation of prostanoids during intravascular complement activation in the rabbit. Br J Pharmacol (1985) 0.97
New cytotoxic steroids from the marine sponge Dysidea fragilis coming from the lagoon of Venice. Steroids (1995) 0.97
Influence of endotoxin on arachidonate metabolism in isolated rabbit peritoneum. Biochem Pharmacol (1983) 0.97
5-hydroxytryptamine and platelet aggregation. Fed Proc (1983) 0.97
Activated complement and anaphylatoxins increase the in vitro production of prostacyclin by rabbit aorta endothelium. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.97
Prostaglandin F2 alpha in benign and malignant breast tumours. Br J Cancer (1985) 0.96
Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta. Br J Pharmacol (1988) 0.96
Role of oxidative stress in the pathogenesis of septic ileus in mice. Neurogastroenterol Motil (2005) 0.96
Role of IL-6 in the pleurisy and lung injury caused by carrageenan. J Immunol (1999) 0.96
Hyaluronic acid modulates acute and chronic inflammation. Agents Actions (1994) 0.96
Non-steroidal anti-inflammatory drugs and leucocyte emigration. J Pharm Pharmacol (1972) 0.95